Skip to main content
. 2012 Oct 2;12:116. doi: 10.1186/1471-2377-12-116

Table 1.

Demographic information

  PSP(n = 19) PD(n = 20) HOA(n = 20)  
Age, yrs
69.1 (8.7)
68.3 (7.9)
71.8 (4.1)
n/s
Male, n(%)
16 (84)
16 (80)
7 (35)
P = 0.001
Height, cm
170.6 (8.2)
171.8 (8.0)
166.6 (6.3)
n/s
Weight, kg
80.5 (13.5)
78.3 (10.2)
68.4 (11.5)
F2,56 = 5.9, P = 0.01
Symptom duration, yrs
4.3 (2.7)
6.6 (5.8)
-
n/s
Disease severity
41.7 (17.2)
14.4 (16.7)
-
-
Normalized speed
1.03 (0.27)
1.28 (0.22)
1.54 (0.16)
F2,56 = 25.8, P < 0.001
Normalized stride length
1.2 (0.2)
1.4 (0.2)
1.6 (0.1)
F2,56 = 25.6, P < 0.001
Cadence (steps/min)
103.6 (9.3)
109.7 (6.9)
113.4 (7.0)
F2,56 = 7.9, P = 0.001
Cadence (steps/min)*
119.8 (15.4)
108.9 (18.9)
92.7 (9.5)
F2,56= 15.9, P <0.001
DS (%)*
31.1 (4.6)
27.9 (3.0)
25.6 (2.7)
F2,56 = 12.2, P < 0.001
Step width (cm)*
11.4 (4.2)
9.0 (2.9)
8.5 (2.9)
F2,56 = 4.0, P = 0.02
Stance time variability (sec)*
0.024 (0.009)
0.018 (0.008)
0.025 (0.013)
n/s
Stride length variability (cm)* 3.2 (1.7) 2.4 (1.2) 2.8 (1.6) n/s

Mean (standard deviation, SD) for each group. Disease severity was measured using PSP Rating Scale for PSP participants (0=no symptoms – 100) and Unified Parkinson’s Disease Rating Scale – motor subsection (UPDRS III) for PD participants (0=no symptoms – 56). Mean (SD) normalized speed, normalized stride length and cadence for preferred speed walks. Mean (SD) of other gait parameters for the walk with normalized stride length closest to 1.4.

* Determined from walk with normalized stride length closest to 1.4. PSP progressive supranuclear palsy, PD Parkinson’s disease, HOA healthy older adult, DS double support percentage of gait cycle, n/s not statistically significant.